Skip to main content
. 2012 Mar 28;7(3):e32894. doi: 10.1371/journal.pone.0032894

Table 1. Baseline characteristics of patients randomized to receive aspirin or control.

Variables Aspirin (nā€Š=ā€Š14) Control (nā€Š=ā€Š16) p
Age, median (IQR) 56.50 (50.00 to 62.00) 63.00 (58.00 to 71.00) 0.051
Female sex, n (%) 6 (42.9) 8 (53.3) 0.573
Body mass index, mean (SD) 31.97 (6.97) 27.85 (4.87) 0.075
Years since diagnosis, median (IQR) 5.00 (1.00 to 13.25) 9.00 (2.00 to 14.00) 0.505
Blood pressure, mmHg mean (SD)
Systolic 125.00 (14.01) 132.33 (18.79) 0.247
Diastolic 83.71 (9.61) 82.33 (10.83) 0.720
Heart rate, bpm mean (SD) 75.21 (5.04) 76.93 (7.74) 0.488
Hypertension, n (%) 7 (50) 10 (66.7) 0.362
Smoker, current or former, n (%) 10 (71.4) 8 (53.3) 0.316
HbA1c, % median (IQR) 6.80 (5.83 to 7.20) 6.40 (5.70 to 7.00) 0.621
Plasma glucose, mean (SD) 133.36 (44.57) 120.27 (26.58) 0.341
Diabetes therapy
Oral hypoglicemic agents, n (%) 11 (78.6) 14 (93.3) 0.330
Metformin 9 (64.3) 10 (66.7) 1.00
Sulfonylurea 6 (42.9) 6 (40.0) 0.876
Insulin, n (%) 4 (28.6) 1 (6.7) 0.169
Total cholesterol, mmol/l median (IQR) 4.9 (4.6 to 5.4) 5.6 (4.7 to 6.1) 0.793
HDL- cholesterol, mmol/l median (IQR) 1.0 (0.9 to 1.4) 1.3 (1 to 1.4) 0.315
LDL- cholesterol, mmol/l median (IQR) 3.1 (2.8 to 3.6) 3.3 (2.5 to 4.0) 0.694
Plasma creatinine, mg/dl mean (SD) 0.77 (0.16) 0.79 (0.13) 0.733
Hematocrit, % mean (SD) 41.40 (4.88) 40.63 (4.74) 0.674
Hemoglobin, gr/dl mean (SD) 13.75 (1.62) 13.33 (1.54) 0.496
Plasma insulin, mean (SD) 12.18 (7.09) 14.55 (5.89) 0.371
HOMA, median (IQR) 4.23 (2.86 to 5.32) 4.47 (3.10 to 5.61) 0.526
C-reactive protein, ng/ml median (IQR) 0.39 (0.08 to 1.6) 0.10 (0.06 to 0.46) 0.218